- ---------------
FORM 3 U.S. SECURITIES AND EXCHANGE COMMISSION
Washington D.C. 20549
- ---------------
INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES
Filed pursuant to Section 16(a) of the Securities Exchange
Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the
Investment Company Act of 1940
- ---------------------------------------------
1. Name and Address of Reporting Person*
Select Medical Corporation
- ---------------------------------------------
(Last) (First) (Middle)
4718 Old Gettysburg Road, P.O. Box 2034
- ---------------------------------------------
Mechanicsburg Pennsylvania 17055
- ---------------------------------------------
(City) (State) (Zip)
- ---------------------------------------------
2. Date of Event Requiring Statement
(Month/Day/Year)
12/15/98
- ---------------------------------------------
3. I.R.S. Identification Number of Reporting
Person, if an entity
23-2872718
- ---------------------------------------------
4. Issuer Name and Ticker or Trading Symbol
Intensiva HealthCare Corporation
(NASDAQ: IHCC)
- ---------------------------------------------
5. Relationship of Reporting Person(s) to
Issuer (Check all applicable)
Director X 10% Owner
Officer (give Other (specify
title below) below)
- ---------------------------------------------
6. If Amendment, Date of Original
(Month/Day/Year)
- ---------------------------------------------
7. Individual or Joint/Group Filing
(Check Applicable List)
X Form filed by One Reporting Person
Form filed by More than One Reporting
person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of 2. Amount of Securities 3. Ownership 4. Nature of Indirect
Security Beneficially Owned Form: Direct Beneficial Ownership
(Instr.4) (Instr4.) (D) or (Instr.5)
Indirect (I)
(Instr. 5)
Common Stock 9,619,379 D N/A
Reminder: Report on a separate line for each class of securities beneficially
owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction
5(b)(v).
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the
form displays a currently valid OMB control number.
(Over)
<PAGE>
FORM 3 (Continued)
<TABLE>
<CAPTION>
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
<S> <C> <C> <C> <C> <C>
1. Title of Derivative 2. Date 3. Title and Amount 4. Conversion 5. Ownership Form 6. Nature of Indirect
Security (Instr. 4) Exercisable of Securities or of Derivative Beneficial Ownership
and Underlying Exercise Security: (Instr. 5)
Expiration Derivative Price of Direct (D) or
Date Security Derivative Indirect (I)
(Month/Day/Year) (Instr. 4) Security (Instr.5)
Date Expir- Title Amount or
Expir- ation Number of
ation Date Shares
</TABLE>
Explanation of Responses:
/s/ Michael E. Tarvin 12/24/98
Michael E. Tarvin Date
Vice President,
General Counsel and
Secretary
** Intentional misstatements or omissions of facts constitute Federal Criminal
Violations.
See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If
space provided is insufficient, See Instruction 6 for procedure.
Potential persons who are to respond to the collection of information
contained in this form are not required to respond unless the form displays
a current valid OMB Number.
